Atlas Trials

Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy

Clinical trial NCT01039155 · COMPLETED

Trial details

NCT number
NCT01039155
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Start date
2009-12-01
Primary completion
2012-09-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.